CAMBRIDGE, Mass., March 8, 2018 /PRNewswire/ -- Infinity
Pharmaceuticals, Inc. (NASDAQ: INFI) will host a conference call on
Thursday, March 15, 2018, at
4:30 p.m. ET to review its fourth
quarter and full year 2017 financial results and provide an update
on the company.
A live webcast of the conference call can be accessed in the
Investors/Media section of Infinity's website at www.infi.com. To
participate in the conference call, please dial 1-877-316-5293
(domestic) and 1-631-291-4526 (international) five minutes prior to
start time. The conference ID number is 5558799. An archived
version of the webcast will be available on Infinity's website for
30 days.
About Infinity
Infinity is an innovative
biopharmaceutical company dedicated to advancing novel medicines
for people with cancer. Infinity is advancing IPI-549, an oral
immuno-oncology development candidate that selectively inhibits
PI3K-gamma. A Phase 1/1b study in
approximately 200 patients with advanced solid tumors is ongoing.
For more information on Infinity, please refer to Infinity's
website at www.infi.com.
Contact:
Stephanie
Ascher, Stern Investor Relations, Inc.
212-362-1200 or Stephanie@sternir.com
View original
content:http://www.prnewswire.com/news-releases/infinity-announces-the-date-of-its-fourth-quarter-and-full-year-2017-financial-results-conference-call-and-webcast-300611022.html
SOURCE Infinity Pharmaceuticals, Inc.